Reuters logo
7 months ago
BRIEF-Kalobios announces positive guidance from FDA for Benznidazole
January 5, 2017 / 4:26 PM / 7 months ago

BRIEF-Kalobios announces positive guidance from FDA for Benznidazole

Jan 5 (Reuters) - Kalobios Pharmaceuticals Inc -

* Kalobios announces positive guidance from FDA for Benznidazole

* Kalobios Pharmaceuticals Inc - Benznidazole eligible for neglected tropical disease priority review voucher

* Kalobios Pharmaceuticals Inc- Minutes received from recent FDA meeting on Benznidazole

* Kalobios Pharmaceuticals Inc - 505(B) regulatory pathway using existing safety and efficacy data is acceptable Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below